Kawahara, Takuya http://orcid.org/0000-0002-3859-2756
Taira, Naruto
Shiroiwa, Takeru
Hagiwara, Yasuhiro
Fukuda, Takashi
Uemura, Yukari
Mukai, Hirofumi
Funding for this research was provided by:
Public Health Research Foundation
Article History
Accepted: 19 December 2021
First Online: 4 January 2022
Declarations
:
: Dr. Mukai received honoraria from Pfizer, Takeda, Daiichi Sankyo and Taiho, and research grants from the Japanese government, Daiichi Sankyo, and Pfizer outside the submitted work. Dr. Mukai is a member of the Board of Directors of the Japan Breast Cancer Society.
: The research ethics boards of all participating institutions approved the protocol of this study. This study was conducted according to the Declaration of Helsinki.
: All patients provided written informed consent.